Literature DB >> 21094253

Tumor necrosis factor-alpha regulates the Hypocretin system via mRNA degradation and ubiquitination.

Shuqin Zhan1, Guo-Qiang Cai, Anni Zheng, Yuping Wang, Jianping Jia, Haotian Fang, Youfeng Yang, Meng Hu, Qiang Ding.   

Abstract

Recent studies recognize that Hypocretin system (also known as Orexin) plays a critical role in sleep/wake disorders and feeding behaviors. However, little is known about the regulation of the Hypocretin system. It is also known that tumor necrosis factor alpha (TNF-α) is involved in the regulation of sleep/wake cycle. Here, we test our hypothesis that the Hypocretin system is regulated by TNF-α. Prepro-Hypocretin and Hypocretin receptor 2 (HcrtR2) can be detected at a very low level in rat B35 neuroblastoma cells. In response to TNF-α, Prepro-Hypocretin mRNA and protein levels are down-regulated, and also HcrtR2 protein level is down-regulated in B35 cells. To investigate the mechanism, exogenous rat Prepro-Hypocretin and rat HcrtR2 were overexpressed in B35 cells. In response to TNF-α, protein and mRNA of Prepro-Hypocretin are significantly decreased (by 93% and 94%, respectively), and the half-life of Prepro-Hypocretin mRNA is decreased in a time- and dose-dependent manner. The level of HcrtR2 mRNA level is not affected by TNF-α treatment; however, HcrtR2 protein level is significantly decreased (by 86%) through ubiquitination in B35 cells treated with TNF-α. Downregulation of cellular inhibitor of apoptosis protein-1 and -2 (cIAP-1 and -2) abrogates the HcrtR2 ubiquitination induced by TNF-α. The control green fluorescent protein (GFP) expression is not affected by TNF-α treatment. These studies demonstrate that TNF-α can impair the function of the Hypocretin system by reducing the levels of both Prepro-Hypocretin and HcrtR2.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21094253      PMCID: PMC3042489          DOI: 10.1016/j.bbadis.2010.11.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  52 in total

Review 1.  Adipokines and the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Peptides       Date:  2007-05-06       Impact factor: 3.750

2.  High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides.

Authors:  T Holmqvist; K E Akerman; J P Kukkonen
Journal:  Neurosci Lett       Date:  2001-06-15       Impact factor: 3.046

3.  Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR.

Authors:  D Smart; J C Jerman; S J Brough; S L Rushton; P R Murdock; F Jewitt; N A Elshourbagy; C E Ellis; D N Middlemiss; F Brown
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 4.  Experimental immunomodulation, sleep, and sleepiness in humans.

Authors:  T Pollmächer; A Schuld; T Kraus; M Haack; D Hinze-Selch; J Mullington
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats.

Authors:  O Jöhren; S J Neidert; M Kummer; A Dendorfer; P Dominiak
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

6.  The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.

Authors:  N Roy; Q L Deveraux; R Takahashi; G S Salvesen; J C Reed
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

Review 7.  To eat or to sleep? Orexin in the regulation of feeding and wakefulness.

Authors:  J T Willie; R M Chemelli; C M Sinton; M Yanagisawa
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

8.  Tumor necrosis factor (TNF) ligand and TNF receptor deficiency affects sleep and the sleep EEG.

Authors:  Tom Deboer; Adriano Fontana; Irene Tobler
Journal:  J Neurophysiol       Date:  2002-08       Impact factor: 2.714

Review 9.  The relationship of obesity and obstructive sleep apnea.

Authors:  Neomi Shah; Francoise Roux
Journal:  Clin Chest Med       Date:  2009-09       Impact factor: 2.878

Review 10.  The role of TNF superfamily members in T-cell function and diseases.

Authors:  Michael Croft
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

View more
  27 in total

Review 1.  Ubiquitination of G protein-coupled receptors: functional implications and drug discovery.

Authors:  Michael R Dores; JoAnn Trejo
Journal:  Mol Pharmacol       Date:  2012-06-14       Impact factor: 4.436

Review 2.  Minireview: ubiquitination-regulated G protein-coupled receptor signaling and trafficking.

Authors:  Verónica Alonso; Peter A Friedman
Journal:  Mol Endocrinol       Date:  2013-03-07

3.  Activation of orexinergic and histaminergic pathway involved in therapeutic effect of histamine H4 receptor antagonist against cisplatin-induced anorexia in mice.

Authors:  Kouichi Yamamoto; Rikuya Okui; Atsushi Yamatodani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-03-27       Impact factor: 3.000

4.  FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis.

Authors:  Qiang Ding; Guo-Qiang Cai; Meng Hu; Youfeng Yang; Anni Zheng; Qinjiu Tang; Candece L Gladson; Haurko Hayasaka; Hongju Wu; Zhiying You; Brian D Southern; Lisa M Grove; S Ohidar Rahaman; Haotian Fang; Mitchell A Olman
Journal:  Am J Pathol       Date:  2013-03-14       Impact factor: 4.307

5.  Neuronal Wiskott-Aldrich syndrome protein (N-WASP) is critical for formation of α-smooth muscle actin filaments during myofibroblast differentiation.

Authors:  Guo-Qiang Cai; Chu-Fang Chou; Meng Hu; Anni Zheng; Louis F Reichardt; Jun-Lin Guan; Haotian Fang; Tracy R Luckhardt; Yong Zhou; Victor J Thannickal; Qiang Ding
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-10       Impact factor: 5.464

6.  Plasma obestatin and autonomic function are altered in orexin-deficient narcolepsy, but ghrelin is unchanged.

Authors:  M S B Huda; H Mani; B H Durham; T M Dovey; J C G Halford; B S Aditya; J H Pinkney; J P Wilding; I K Hart
Journal:  Endocrine       Date:  2012-11-23       Impact factor: 3.633

7.  Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson's disease.

Authors:  Milos Stanojlovic; Jean Pierre Pallais; Michael K Lee; Catherine M Kotz
Journal:  Mol Brain       Date:  2019-10-30       Impact factor: 4.041

8.  N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

Authors:  Shih Chang Hsueh; Weiming Luo; David Tweedie; Dong Seok Kim; Yu Kyung Kim; Inho Hwang; Jung-Eun Gil; Baek-Soo Han; Yung-Hsiao Chiang; Warren Selman; Barry J Hoffer; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-30

Review 9.  The role of orexin in post-stroke inflammation, cognitive decline, and depression.

Authors:  Juhyun Song; Eosu Kim; Chul-Hoon Kim; Ho-Taek Song; Jong Eun Lee
Journal:  Mol Brain       Date:  2015-03-11       Impact factor: 4.041

Review 10.  A Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease.

Authors:  Ian A Clark; Bryce Vissel
Journal:  Neural Plast       Date:  2015-07-22       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.